Advisory: Alert on Nanobiotix completing phase 1 study of NBTXR3 repeats earlier story

Nanobiotix SA

10/12/2024 16:35

Dec 10 (Reuters) - Please ignore the alert on Nanobiotix
completing phase 1 study of NBTXR3 in pancreatic cancer as it
was sent from a release dated Dec. 9.
    For the above-mentioned release, please click here:
 urn:newsml:reuters.com:*:nGNE4Mb8PZ.
    
STORY_NUMBER: FWN3NB0ZB 
STORY_DATE: 10/12/2024 
STORY_TIME: 04:28:21 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))